OVIDREL
As listed in the register: OVIDREL
250 mcg · solution
- Prescription only
- Urinary and reproductive system, hormones
- Active substance
- Choriogonadotropin Alfa
- Made by
- Emd Serono, A Division Of Emd Inc., Canada
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Pregnyl). It describes the substance, not this exact product.
The action of human chorionic gonadotropin (hCG) is virtually identical to that of pituitary LH, although hCG appears to have a small degree of FSH activity as well.
It stimulates production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens and the corpus luteum of the ovary to produce progesterone.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-02
Safety of the active substance
From the US prescribing label for the same active substance (Pregnyl). It describes the substance, not this exact product.
- Prior hypersensitivity reactions to human gonadotropins, including hCG, or any of the excipients (see ADVERSE REACTIONS ).
- High serum FSH, indicating primary gonadal failure in women.
- Presence of uncontrolled non-gonadal endocrinopathies (e.g., thyroid, adrenal, or pituitary disorders).
- Tumors of the hypothalamus or pituitary gland and ovary, breast, or uterus in females and breast or prostate in males.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Emd Serono, A Division Of Emd Inc., Canada |
|---|---|
| Active substance | Choriogonadotropin Alfa |
| Used in | Urinary and reproductive system, hormones |
| Strength | 250 mcg |
| Form | solution |
| Classification | G03GA08 · Urinary and reproductive system, hormones |
| Route | subcutaneous |
| Dispensing (as stated by the register) | PRESCRIPTION · SCHEDULE D |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02371588 |
| DPD drug code | 85673 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution2 products
250 mcg2
250 mcg · 2 companies
- Emd Serono, A Division Of Emd Inc., Canada · this page
- Emd Serono, A Division Of Emd Inc., Canada
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.